ThreatsDay Bulletin tracks active exploits, phishing waves, AI risks, major flaws, and cybercrime crackdowns shaping this week’s threat landscape.
The FDA has introduced a new approval process for targeted individualized therapies, including genome editing and RNA-based therapies, intended to treat rare and ultra rare diseases in which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results